Baudax Bio, Inc.
SEC CIK 1780097 · BXRX · last insider filing 2023-10-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kim Yong Chan | Director | filed 2023 - 2023 |
| Henwood Geraldine | Director · President and CEO | filed 2019 - 2022 |
| Drechsler Andrew T | Director | filed 2020 - 2022 |
| Ashton William | Director | filed 2019 - 2022 |
| Weisman Wayne | Director | filed 2019 - 2022 |
| Baskies Arnold M | Director | filed 2020 - 2022 |
| Churchill Winston J | Director | filed 2019 - 2022 |
| Altomari Alfred | Director | filed 2019 - 2021 |
| Lake Ryan David | Director · Chief Financial Officer | filed 2019 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mcandrew Natalie | Interim CFO | filed 2023 - 2023 |
| Dilmore Jillian | Corporate Controller/Secretary | filed 2022 - 2022 |
| Casten Richard S | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.